Table 3.
Univariate and multivariate analyses of prognostic factors for overall survival in 86 LUAD cases
| Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| RR(95% CI) | P-value | RR(95% CI) | P-value | |
| Age | 1.648 | 0.218 | – | – |
| <65 years vs ≥65 years | (0.753–3.517) | |||
| Gender | 0.833 | 0.675 | – | – |
| Male vs female | (0.358–1.9) | |||
|
Differentiation Grades I-II vs Grade III |
1.502 (1.66–3.38) |
0.326 | – | – |
|
T stage T3-T4 vs T1-T2 |
2.483 (1.228–5.808) |
0.013 | 1.395 (0.554–2.512) |
0.391 |
|
Lymph node metastasis Positive vs negative |
2.515 (1.297–6.990) |
0.010 | 2.354 (0.914–5.913) |
0.946 |
|
TNM stage IV- IIB vs IA–IIA |
3.454 (1.429–6.292) |
0.003 | 2.796 (1.101–7.099) |
0.031 |
|
FAM111B expression High vs low |
2.933 (1.383–6.211) |
0.005 | 2.299 (1.015–5.205) |
0.046 |
Abbreviations: LUAD, lung adenocarcinoma; RR, risk ratio.